News
Discover Insmed's innovative therapies targeting rare diseases, with approvals like Brinsupri boosting potential.
The FDA has approved Insmed’s Brinsupri™ (brensocatib 10 mg and 25 mg tablets) as the first drug authorized to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback